CONTACTAbout UsCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Equal Entertainment LLC.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
We need your help
Your support makes The Advocate's original LGBTQ+ reporting possible. Become a member today to help us continue this work.
Your support makes The Advocate's original LGBTQ+ reporting possible. Become a member today to help us continue this work.
The U.S. Food and Drug Administration has approved a programmable device that will allow medical professionals to monitor when and how patients take their medications, reported Forbes on Thursday.
The Electronic Medication Management Assistant (EMMA) will be able to prevent drug identification problems and dosing errors. Medication errors harm approximately 1.5 million Americans each year, according to a 2006 study from the Institute of Medicine.
This system will be useful for aging patients suffering from memory loss and people with complex prescriptions, such as those living with HIV, the FDA explained to Forbes.
EMMA is composed of a storage and delivery unit fitted with two-way communication software that allows a healthcare provider to remotely monitor the dispersal of medications. An alarm alerts the patient when it is time to take a medication, dispensing the correct pills into a delivery tray.
The EMMA system was developed by Pennsylvania-based INRange Systems. (The Advocate)
From our Sponsors
Most Popular
Watch Now: Pride Today
Latest Stories
Detroit trans woman Karmin Wells shot and killed
July 16 2025 5:53 PM
Daily newsletter 7/16
July 16 2025 5:12 PM
5,000 users leave trans subreddit in wake of transmasculine controversy
July 16 2025 4:10 PM
Cooper Koch’s Emmy nomination earned him a surprise prison call
July 16 2025 3:47 PM
Florida officials claim SCOTUS ruling allows them to deny trans adults health care
July 16 2025 2:43 PM